Sanofi (ETR: SNW)

Sanofi Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	45,566	43,070	42,997	37,761	36,041	36,126
Other Revenue	2,879	2,963	2,392	1,414	1,328	1,505
Revenue	48,445	46,033	45,389	39,175	37,369	37,631
Revenue Growth (YoY)	6.01%	1.42%	15.86%	4.83%	-0.70%	5.48%
Cost of Revenue	14,962	14,216	13,692	12,251	12,106	11,976
Gross Profit	33,483	31,817	31,697	26,924	25,263	25,655
Selling, General & Admin	10,945	10,765	10,539	9,599	9,448	9,967
Research & Development	7,147	6,728	6,706	5,692	5,530	6,020
Other Operating Expenses	4,312	2,950	1,587	1,488	1,025	720
Operating Expenses	24,519	22,615	20,659	18,359	17,684	18,853
Operating Income	8,964	9,202	11,038	8,565	7,579	6,802
Interest Expense	-690	-527	-394	-362	-459	-544
Interest & Investment Income	531	546	173	3	37	91
Earnings From Equity Investments	-63	-115	68	39	359	255
Currency Exchange Gain (Loss)	-2	-2	-4	2	-6	1
Other Non Operating Income (Expenses)	-665	-665	37	70	144	236
EBT Excluding Unusual Items	8,075	8,439	10,918	8,317	7,654	6,841
Merger & Restructuring Charges	-2,291	-1,510	-1,339	-824	-1,142	-1,091
Gain (Loss) on Sale of Investments	-1	-1	1	3	7,388	-
Gain (Loss) on Sale of Assets	688	688	655	418	443	296
Asset Writedown	-686	-896	228	-192	-330	-3,604
Legal Settlements	-	-	-	-	-	327
Other Unusual Items	273	318	27	115	124	238
Pretax Income	6,058	7,038	10,490	7,837	14,137	3,007
Income Tax Expense	1,509	1,602	2,006	1,558	1,807	121
Earnings From Continuing Operations	4,549	5,436	8,484	6,279	12,330	2,886
Earnings From Discontinued Operations	-	-	-	-	-	-101
Net Income to Company	4,549	5,436	8,484	6,279	12,330	2,785
Minority Interest in Earnings	-43	-36	-113	-56	-36	-31
Net Income	4,506	5,400	8,371	6,223	12,294	2,754
Net Income to Common	4,506	5,400	8,371	6,223	12,294	2,754
Net Income Growth	-50.30%	-35.49%	34.52%	-49.38%	346.41%	-36.04%
Shares Outstanding (Basic)	1,251	1,252	1,252	1,253	1,254	1,250
Shares Outstanding (Diluted)	1,256	1,256	1,257	1,258	1,260	1,257
Shares Change (YoY)	-0.05%	-0.04%	-0.08%	-0.17%	0.24%	0.15%
EPS (Basic)	3.60	4.31	6.69	4.97	9.81	2.20
EPS (Diluted)	3.59	4.30	6.66	4.95	9.76	2.19
EPS Growth	-50.24%	-35.44%	34.55%	-49.28%	345.73%	-36.15%
Free Cash Flow	-	8,539	8,920	9,044	6,164	6,392
Free Cash Flow Per Share	-	6.80	7.10	7.19	4.89	5.08
Dividend Per Share	-	3.760	3.560	3.330	3.200	3.150
Dividend Growth	-	5.62%	6.91%	4.06%	1.59%	2.61%
Gross Margin	69.12%	69.12%	69.83%	68.73%	67.60%	68.18%
Operating Margin	18.50%	19.99%	24.32%	21.86%	20.28%	18.08%
Profit Margin	9.30%	11.73%	18.44%	15.89%	32.90%	7.32%
Free Cash Flow Margin	-	18.55%	19.65%	23.09%	16.49%	16.99%
EBITDA	12,503	12,520	14,062	11,251	10,466	10,113
EBITDA Margin	25.81%	27.20%	30.98%	28.72%	28.01%	26.87%
D&A For EBITDA	3,539	3,318	3,024	2,686	2,887	3,311
EBIT	8,964	9,202	11,038	8,565	7,579	6,802
EBIT Margin	18.50%	19.99%	24.32%	21.86%	20.28%	18.08%
Effective Tax Rate	24.91%	22.76%	19.12%	19.88%	12.78%	4.02%

Source: S&P Capital IQ. Standard template. Financial Sources.